The Current Ratio as of November 2024 (TTM) for Syros Pharmaceuticals, Inc. (SYRS) is 2.25

According to Syros Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.25. This represents a change of -28.94% compared to the average of 3.17 of the last 4 quarters.

Syros Pharmaceuticals, Inc. (SYRS) Historical Current Ratio (quarterly & annually)

How has SYRS Current Ratio performed in the past?

The mean historical Current Ratio of Syros Pharmaceuticals, Inc. over the last ten years is 9.92. The current 2.25 Current Ratio has changed 2.17% with respect to the historical average. Over the past ten years (40 quarters), SYRS's Current Ratio was at its highest in in the December 2014 quarter at 48.36. The Current Ratio was at its lowest in in the March 2015 quarter at 0.

Syros Pharmaceuticals, Inc. (SYRS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Syros Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Syros Pharmaceuticals, Inc. (SYRS) Average Current Ratio

How has SYRS Current Ratio performed in the past?

The current Current Ratio of Syros Pharmaceuticals, Inc. (SYRS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Syros Pharmaceuticals, Inc. (SYRS) Current Ratio vs. Peers

How is SYRS’s Current Ratio compared to its peers?

Syros Pharmaceuticals, Inc.’s Current Ratio is less than Surrozen, Inc. (7.40), less than Bolt Biotherapeutics, Inc. (3.16), less than Larimar Therapeutics, Inc. (13.10), less than Keros Therapeutics, Inc. (19.03), less than Kezar Life Sciences, Inc. (7.65), less than IDEAYA Biosciences, Inc. (22.93), less than Syndax Pharmaceuticals, Inc. (6.99), less than Xencor, Inc. (6.23), less than REGENXBIO Inc. (3.05), less than Crinetics Pharmaceuticals, Inc. (16.38), less than Black Diamond Therapeutics, Inc. (5.55), less than Stoke Therapeutics, Inc. (5.09), less than Homology Medicines, Inc. (4.19), greater than Harpoon Therapeutics, Inc. (1.89), less than Passage Bio, Inc. (5.15), less than Pasithea Therapeutics Corp. (14.81), less than Kronos Bio, Inc. (8.32), less than Quoin Pharmaceuticals, Ltd. (3.02), less than RenovoRx, Inc. (5.40), less than Spero Therapeutics, Inc. (2.68), greater than Coherus BioSciences, Inc. (1.25), less than Gracell Biotechnologies Inc. (7.73), less than Neoleukin Therapeutics, Inc. (15.33),

Build a custom stock screener for Syros Pharmaceuticals, Inc. (SYRS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Syros Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Syros Pharmaceuticals, Inc. (SYRS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Syros Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.